within Pharmacolibrary.Drugs.ATC.S;

model S02AA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 0.00016666666666666666,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Clioquinol is an antifungal and antibacterial agent formerly used as a topical and oral treatment for a range of infections, including dermatological and ear infections, and certain protozoal parasitic diseases. Due to safety concerns, including subacute myelo-optic neuropathy (SMON), its use systemically has been largely discontinued and it is now primarily available for topical or otic use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for systemic (oral) or local (otic, topical) use in humans are not well-characterized in the published literature. No comprehensive PK data are available; estimates are presented based on general properties of similar compounds and limited case reports.</p><h4>References</h4><ol><li>Xinliang Mao, Aaron D Schimmer,The toxicology of Clioquinol.,Toxicology letters,2008<a href='https://pubmed.ncbi.nlm.nih.gov/18812216/'>https://pubmed.ncbi.nlm.nih.gov/18812216/</a></li><li>Gianpietro Bondiolotti, Mariaelvina Sala, Claudia Pollera, Marco Gervasoni, Maria Puricelli, Wilma Ponti, Silvio R Bareggi,Pharmacokinetics and distribution of clioquinol in golden hamsters.,The Journal of pharmacy and pharmacology,2007<a href='https://pubmed.ncbi.nlm.nih.gov/17331342/'>https://pubmed.ncbi.nlm.nih.gov/17331342/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S02AA05;
